-
Federal
Use of antihypertensive medications in pregnancy and the risk of adverse perinatal outcomes: McMaster Outcome Study of Hypertension In Pregnancy 2 (
U.S. Department of Health & Human Services —
Background Uncertainty remains about the potential harmful effects of antihypertensive therapy on the developing fetus, especially for beta-blockers (βb). Methods We... -
Federal
Humoral immune response to an allogenic foetus in normal fertile women and recurrent aborters
U.S. Department of Health & Human Services —
Background Several humoral immune factors are responsible for a successful pregnancy. There are a few studies, which demonstrate the role of antipaternal cytotoxic... -
Federal
Substance Use during Pregnancy Varies by Race and Ethnicity (2002 to 2010 NSDUH)
U.S. Department of Health & Human Services —
This report uses 2002 to 2010 National Survey on Drug Use and Health (NSDUH) to assess past month illicit drug, alcohol, and cigarette use among pregnant women aged... -
Federal
Drug therapy and adverse drug reactions to terbutaline in obstetric patients: a prospective cohort study in hospitalized women
U.S. Department of Health & Human Services —
Background Adverse drug reactions (ADR's) could be expected more frequently in pregnant women. This study was performed in order to identify ADR's to tocolytic drugs...